BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,039,495 | +2.9% | 289,701 | +21.9% | 0.01% | 0.0% |
| Q1 2023 | $1,981,709 | -8.2% | 237,615 | +26.4% | 0.01% | -12.5% |
| Q4 2022 | $2,158,229 | +3.6% | 187,999 | +13.7% | 0.01% | 0.0% |
| Q3 2022 | $2,083,000 | -21.1% | 165,341 | -33.8% | 0.01% | -20.0% |
| Q2 2022 | $2,641,000 | +14.1% | 249,639 | +75.3% | 0.01% | +42.9% |
| Q1 2022 | $2,315,000 | -29.2% | 142,377 | -39.7% | 0.01% | -22.2% |
| Q4 2021 | $3,272,000 | +23.1% | 236,217 | +27.8% | 0.01% | +12.5% |
| Q3 2021 | $2,657,000 | -2.8% | 184,890 | +6.9% | 0.01% | -11.1% |
| Q2 2021 | $2,734,000 | +168.8% | 172,901 | +72.9% | 0.01% | +125.0% |
| Q1 2021 | $1,017,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |